Challenges in diagnosis and treatment of fascioliasis in a non-endemic country

J Travel Med. 2025 Jan 9:taae152. doi: 10.1093/jtm/taae152. Online ahead of print.

Shira Dor¹, Ronit Cohen-Poradosu², David Hochstein¹, Tamar Grossman³, Inger Mathiesen⁴, Rashed Saed⁵, Hefziba Green^{5

6}, Michal Amitai^{7

8}, Eli Schwartz^{9

7}, Eyal Leshem^{9

7}

¹ Department of Internal Medicine C, Sheba Medical Center, 2 Derech Sheba, Ramat Gan, Israel, 5262000,Tel-Hashomer, Israel.
² Department of Infectious Diseases, Kaplan Medical Center, Pasternak St. P.O. Box 1, Rehovot 76100, Israel.
³ Public Health Laboratories-Jerusalem (PHL-J), Public Health Services (PHS), Ministry of Health (MOH), 9 Yaakov Eliav St. P.O. Box 34410 Jerusalem 9134302, Israel.
⁴ Department of Infectious Diseases, University Hospital Rigshospitalet, Blegdamsvej 9, 2100 København Copenhagen, Denmark.
⁵ Department of Internal Medicine A, Kaplan Medical Center, Pasternak St. P.O. Box 1, Rehovot 76100, Israel.
⁶ Faculty of Medicine, Hebrew University of Jerusalem, Ein Karem P.O. Box 12272, Jerusalem 9112102, Israel.
⁷ School of Medicine, Tel Aviv University, P.O.B 39040. Ramat Aviv, Tel Aviv 69978, Israel.
⁸ Department of Radiology, Sheba Medical Center, 2 Derech Sheba, Tel-Hashomer, Ramat Gan, 5262000, Israel.
⁹ Department of Infectious Diseases, Sheba Medical Center, 2 Derech Sheba, Tel-Hashomer, Ramat Gan, 5262000, Israel.

No abstract available

Keywords: Fascioliasis; diagnosis; fasciola; non-endemic; treatment.